- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 31 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.12: 3 residues within 4Å:- Chain A: N.137, Q.169, N.171
Ligand excluded by PLIPNAG.13: 1 residues within 4Å:- Chain A: N.212
Ligand excluded by PLIPNAG.14: 1 residues within 4Å:- Chain A: N.713
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain A: A.932, N.935, N.936, G.940
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain A: V.1192, N.1193, M.1197
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: S.654, I.673, T.674, N.675
Ligand excluded by PLIPNAG.18: 4 residues within 4Å:- Chain A: N.695, Y.759, S.760, K.761
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: E.646, V.647, N.648
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: K.352, A.448, N.449
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain A: V.1222, N.1223
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain A: N.787
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain B: L.159, N.212
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: P.446, N.449
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: F.712, N.713
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain B: V.786, N.787, Q.800
Ligand excluded by PLIPNAG.27: 5 residues within 4Å:- Chain B: A.932, N.936, G.940, A.941, E.942
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain B: S.654, R.670, I.673, N.675
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: H.693, N.695, K.761
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain B: N.648
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain B: N.342, N.371, S.374, T.616
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: V.1222, N.1223
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain C: N.212
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain C: A.448, N.449
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain C: N.713
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain C: N.787
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain C: A.932, A.933, N.936
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: V.1192, N.1193, M.1197
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: I.673, N.675
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: H.693, N.695, Y.759
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: V.647, N.648
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: D.892, Q.1013
- Chain C: N.1223
Ligand excluded by PLIP- 3 x PLM: PALMITIC ACID(Non-covalent)
PLM.33: 14 residues within 4Å:- Chain A: F.370, M.372, L.375, M.376, I.379, F.384, A.391, Y.395, I.402, L.603, L.605
- Chain B: N.421, L.422, G.423
13 PLIP interactions:10 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:F.370, A:L.375, A:L.375, A:I.379, A:I.379, A:F.384, A:I.402, A:L.603, A:L.605, B:N.421
- Hydrogen bonds: A:Y.395, B:L.422, B:G.423
PLM.34: 14 residues within 4Å:- Chain B: M.372, L.375, M.376, I.379, A.391, A.392, Y.395, L.441, L.603
- Chain C: V.415, D.416, N.421, L.422, G.423
10 PLIP interactions:6 interactions with chain B, 4 interactions with chain C- Hydrophobic interactions: B:L.375, B:M.376, B:L.441, B:L.441, B:L.603, C:V.415, C:N.421
- Hydrogen bonds: B:Y.395, C:L.422, C:G.423
PLM.45: 15 residues within 4Å:- Chain A: D.416, G.420, N.421, L.422, G.423
- Chain C: F.370, M.372, L.375, M.376, A.391, A.392, I.394, Y.395, I.402, L.603
8 PLIP interactions:3 interactions with chain A, 5 interactions with chain C- Hydrophobic interactions: A:N.421, C:F.370, C:L.375, C:I.402, C:L.603
- Hydrogen bonds: A:L.422, A:G.423, C:Y.395
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bangaru, S. et al., Structural mapping of antibody landscapes to human betacoronavirus spike proteins. Sci Adv (2022)
- Release Date
- 2022-05-04
- Peptides
- Spike protein: ABC
Human polyclonal Fab model with polyalanine backbone - Heavy chain: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
BC
AD
HE
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-mer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 31 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x PLM: PALMITIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bangaru, S. et al., Structural mapping of antibody landscapes to human betacoronavirus spike proteins. Sci Adv (2022)
- Release Date
- 2022-05-04
- Peptides
- Spike protein: ABC
Human polyclonal Fab model with polyalanine backbone - Heavy chain: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
BC
AD
HE
L